Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Radhakrishnan Anup Insider Profile
4 Followers
Radhakrishnan Anup, CFO and COO at CARGO Therapeutics, Inc., holds 6.45K shares in CARGO Therapeutics, Inc. (Ticker: CRGX).
Radhakrishnan Anup has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Radhakrishnan Anup's holdings
Insider Roles
CFO and COO
Roles that Radhakrishnan Anup holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Radhakrishnan Anup
Radhakrishnan Anup's Trading History
List of latest transactions for each holding click on a transaction to see Radhakrishnan Anup's performance on stock
You May Also Like
Radhakrishnan Anup insider profile FAQ
What is the percentage of profitable transactions made by Radhakrishnan Anup?
The percentage of profitable transactions made by Radhakrishnan Anup is ―.
What is the average return per transaction made by Radhakrishnan Anup?
The average return per transaction made by Radhakrishnan Anup is ―.
What stocks does Radhakrishnan Anup hold?
Radhakrishnan Anup holds: CRGX stocks.
What was Radhakrishnan Anup’s latest transaction?
Radhakrishnan Anup latest transaction was an Uninformative Buy of $8.05K.
What was Radhakrishnan Anup's most profitable transaction?
Radhakrishnan Anup’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Radhakrishnan Anup's role in CARGO Therapeutics, Inc.?
Radhakrishnan Anup's role in CARGO Therapeutics, Inc. is CFO and COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.